Carboxypeptidase E modulates intestinal immune homeostasis and protects against experimental colitis in mice.
Enteroendocrine cells (EEC) produce neuropeptides, which are crucially involved in the maintenance of the intestinal barrier. Hence, EEC dysfunction is suggested to be involved in the complex pathophysiology of inflammatory bowel disease (IBD), which is characterized by decreased intestinal barrier...
Main Authors: | Florian Bär, Bandik Föh, René Pagel, Torsten Schröder, Heidi Schlichting, Misa Hirose, Susanne Lemcke, Antje Klinger, Peter König, Christian M Karsten, Jürgen Büning, Hendrik Lehnert, Klaus Fellermann, Saleh M Ibrahim, Christian Sina |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4106776?pdf=render |
Similar Items
-
Seasonal Clock Changes Are Underappreciated Health Risks—Also in IBD?
by: Bandik Föh, et al.
Published: (2019-05-01) -
Crystal structure of carboxypeptidase Gâ†2
by: Rowsell, Sian
Published: (1996) -
Processing of the oxytocin precursor by carboxypeptidase E
by: Bleakman, Alexandra
Published: (1990) -
Regulation of dopamine transporter activity by carboxypeptidase E
by: Zhang Heping, et al.
Published: (2009-05-01) -
The synthesis and testing of cyclopropane inhibitors of Carboxypeptidase A
by: Ner, S. K.
Published: (1986)